BRIEF—LEO and DKSH partner on derma and thrombosis products in Asia

Privately-held Danish dermatology specialist LEO Pharma and Swiss market expansion services provider DKSH have entered into an agreement to bring therapeutic products for skin conditions and thrombosis to patients across Asia.

Partnering in Hong Kong, Malaysia, Singapore, Taiwan, Thailand, Vietnam, and the Philippines, the two companies seek to solidify brand presence, grow market share, and ultimately improve patient health outcomes in the region.

DKSH will build dedicated sales and marketing teams on the ground in Asia and manage logistics and product distribution in these markets, ensuring LEO products reach modern trade, traditional trade, hospitals, clinics, and other medical channels, as well as patients in need.

Khalid Aouidat, vice president, responsible for commercial activities in Southeast Asia at LEO, said: “DKSH’s experience and strong regional footprint in Asia, as well as their marketing and sales expertise should help to further strengthen LEO Pharma’s brand and its continued growth.”